1. Home
  2. TVTX vs SEZL Comparison

TVTX vs SEZL Comparison

Compare TVTX & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • SEZL
  • Stock Information
  • Founded
  • TVTX 2008
  • SEZL 2016
  • Country
  • TVTX United States
  • SEZL United States
  • Employees
  • TVTX N/A
  • SEZL N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • SEZL Diversified Financial Services
  • Sector
  • TVTX Health Care
  • SEZL Finance
  • Exchange
  • TVTX Nasdaq
  • SEZL Nasdaq
  • Market Cap
  • TVTX 2.5B
  • SEZL 3.0B
  • IPO Year
  • TVTX N/A
  • SEZL N/A
  • Fundamental
  • Price
  • TVTX $29.05
  • SEZL $77.69
  • Analyst Decision
  • TVTX Strong Buy
  • SEZL Buy
  • Analyst Count
  • TVTX 15
  • SEZL 4
  • Target Price
  • TVTX $34.86
  • SEZL $113.75
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • SEZL 765.0K
  • Earning Date
  • TVTX 10-30-2025
  • SEZL 11-05-2025
  • Dividend Yield
  • TVTX N/A
  • SEZL N/A
  • EPS Growth
  • TVTX N/A
  • SEZL 146.46
  • EPS
  • TVTX N/A
  • SEZL 2.93
  • Revenue
  • TVTX $333,865,000.00
  • SEZL $371,794,890.00
  • Revenue This Year
  • TVTX $83.23
  • SEZL $65.77
  • Revenue Next Year
  • TVTX $41.49
  • SEZL $27.29
  • P/E Ratio
  • TVTX N/A
  • SEZL $26.22
  • Revenue Growth
  • TVTX 87.94
  • SEZL 92.95
  • 52 Week Low
  • TVTX $12.91
  • SEZL $24.86
  • 52 Week High
  • TVTX $28.85
  • SEZL $186.74
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 73.62
  • SEZL 42.74
  • Support Level
  • TVTX $26.79
  • SEZL $70.63
  • Resistance Level
  • TVTX $28.24
  • SEZL $80.00
  • Average True Range (ATR)
  • TVTX 1.02
  • SEZL 4.32
  • MACD
  • TVTX -0.01
  • SEZL 0.68
  • Stochastic Oscillator
  • TVTX 100.00
  • SEZL 49.84

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

Share on Social Networks: